Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Thoracic Cancer
|
November 22, 2021
Construction of a circular RNA-microRNA-messenger RNA regulatory network of hsa_circ_0043256 in lung cancer by integrated analysis
Yongwen Li, Ruifeng Shi, Guangsheng Zhu, et al.
Journal of Cancer
|
June 17, 2022
Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Lung Adenocarcinoma
Hua Huang, Guangsheng Zhu, Ruifeng Shi, et al.
Frontiers in Chemistry
|
April 11, 2022
Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer
Peijun Cao, Yongwen Li, Ruifeng Shi, et al.
Nucleic Acids Research
|
February 21, 2019
MRE11 UFMylation promotes ATM activation
Zhifeng Wang, Yamin Gong, Bin Peng, et al.
Frontiers in Oncology
|
March 21, 2022
Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
Hua Huang, Zijian Shi, Yongwen Li, et al.
Oncotargets and Therapy
|
July 10, 2023
Exploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han Population
Min Gao, Yongwen Li, Hua Huang, et al.
Bioorganic Chemistry
|
October 25, 2019
Synthesis and cytotoxic activity of chalcone analogues containing a thieno[2,3-d]pyrimidin-2-yl group as the A-ring or B-ring
Fu-Cheng Wang, Bin Peng, Sheng-Li Cao, et al.
Cell Death & Disease
|
September 4, 2024
L3MBTL1, a polycomb protein, promotes Osimertinib acquired resistance through epigenetic regulation of DNA damage response in lung adenocarcinoma
Zihe Zhang, Yongwen Li, Ruifeng Shi, et al.
Oxidative Medicine and Cellular Longevity
|
July 23, 2016
Tissue Kallikrein Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the B2R-ERK1/2-CREB-Bcl-2 Signaling Pathway in Diabetic Rats
Ruifeng Shi, Kunxiong Yuan, Bin Hu, et al.
European Journal of Medicinal Chemistry
|
November 26, 2018
Synthesis and evaluation of chalcone analogues containing a 4-oxoquinazolin-2-yl group as potential anti-tumor agents
Xue Han, Bin Peng, Bei-Bei Xiao, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Thoracic Cancer
|
November 22, 2021
Construction of a circular RNA-microRNA-messenger RNA regulatory network of hsa_circ_0043256 in lung cancer by integrated analysis
Yongwen Li, Ruifeng Shi, Guangsheng Zhu, et al.
Journal of Cancer
|
June 17, 2022
Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Lung Adenocarcinoma
Hua Huang, Guangsheng Zhu, Ruifeng Shi, et al.
Frontiers in Chemistry
|
April 11, 2022
Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer
Peijun Cao, Yongwen Li, Ruifeng Shi, et al.
Nucleic Acids Research
|
February 21, 2019
MRE11 UFMylation promotes ATM activation
Zhifeng Wang, Yamin Gong, Bin Peng, et al.
Frontiers in Oncology
|
March 21, 2022
Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
Hua Huang, Zijian Shi, Yongwen Li, et al.
Oncotargets and Therapy
|
July 10, 2023
Exploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han Population
Min Gao, Yongwen Li, Hua Huang, et al.
Bioorganic Chemistry
|
October 25, 2019
Synthesis and cytotoxic activity of chalcone analogues containing a thieno[2,3-d]pyrimidin-2-yl group as the A-ring or B-ring
Fu-Cheng Wang, Bin Peng, Sheng-Li Cao, et al.
Cell Death & Disease
|
September 4, 2024
L3MBTL1, a polycomb protein, promotes Osimertinib acquired resistance through epigenetic regulation of DNA damage response in lung adenocarcinoma
Zihe Zhang, Yongwen Li, Ruifeng Shi, et al.
Oxidative Medicine and Cellular Longevity
|
July 23, 2016
Tissue Kallikrein Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the B2R-ERK1/2-CREB-Bcl-2 Signaling Pathway in Diabetic Rats
Ruifeng Shi, Kunxiong Yuan, Bin Hu, et al.
European Journal of Medicinal Chemistry
|
November 26, 2018
Synthesis and evaluation of chalcone analogues containing a 4-oxoquinazolin-2-yl group as potential anti-tumor agents
Xue Han, Bin Peng, Bei-Bei Xiao, et al.
Page
of 7